Detalles de la búsqueda
1.
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC.
JTO Clin Res Rep;
5(3): 100638, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38455595
2.
Multi-institutional study of osimertinib dose-optimization in non-small cell lung cancer patients with EGFR activating mutation aged 70 years or older ('MONEY' trial).
Jpn J Clin Oncol;
54(6): 730-734, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38520037
3.
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).
Clin Cancer Res;
30(6): 1104-1110, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165684
4.
First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon EGFR Mutations: The UNICORN Phase 2 Nonrandomized Clinical Trial.
JAMA Oncol;
10(1): 43-51, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37991747
5.
Relationship between stable cesium concentration and body size of Japanese flounder Paralichthys olivaceus and the effect of a size-dependent shift in diet.
J Fish Biol;
104(3): 866-877, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38009686
6.
A Phase â ¡ Study of Ubenimex Combined With Pembrolizumab, Nab-Paclitaxel, and Carboplatin for Previously Untreated Advanced Squamous Non-Small-Cell Lung Cancer: TORG2241 (UBE-Q).
Clin Lung Cancer;
25(1): 85-90, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37981477
7.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci;
115(2): 540-554, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38098261
8.
Pooled Analysis of Studies Evaluating Fosnetupitant and Risk Factors for Cisplatin-Induced Nausea and Vomiting During the Extended Overall Phase.
Adv Ther;
40(11): 4928-4944, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37715851
9.
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer.
Cancer Med;
12(17): 17731-17739, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37691552
10.
Pulmonary manifestation of inflammatory bowel disease: Two case reports.
Respir Med Case Rep;
45: 101914, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37719886
11.
Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report.
Onco Targets Ther;
16: 465-470, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37384219
12.
Quality of life with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: quality of life analysis of TORG 0503.
Qual Life Res;
32(9): 2629-2637, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37126140
13.
Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial.
Lung Cancer;
181: 107195, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37156212
14.
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study.
Int J Clin Oncol;
28(7): 872-879, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171692
15.
Standard versus low-dose nab-paclitaxel in previously treated patients with advanced non-small cell lung cancer: A randomized phase II trial (JMTO LC14-01).
Cancer Med;
12(8): 9133-9143, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36807519
16.
Successful Treatment with Definitive Concurrent Chemoradiotherapy Followed by Durvalumab Maintenance Therapy in a Patient with Tracheal Adenoid Cystic Carcinoma.
Intern Med;
62(18): 2731-2735, 2023 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36642523
17.
Serum-derived exosomal miR-125a-3p predicts the response to anti-programmed cell death-1/programmed cell death-ligand 1 monotherapy in patients with non-small cell lung cancer.
Gene;
857: 147177, 2023 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36623674
18.
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report.
Onco Targets Ther;
16: 65-69, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36718244
19.
Dataset for the establishment of an age model of marine sediment core KH19-6 Leg.4 PC10/MC14 collected from the Agulhas Ridge in the South Atlantic Ocean.
Data Brief;
46: 108797, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36544568
20.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non-Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study.
J Clin Oncol;
41(11): 1986-1991, 2023 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36306479